Virtual Medicinal Product (VMP)
-
Afamelanotide 16mg implant
Name Details
Current Name
Afamelanotide 16mg implant
|
Start Date
01-07-2020
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- device
- Unit Dose UOM
- device
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Subcutaneous
- Form
- Prolonged-release subcutaneous implant
- Ontology Form/Route
- implant.subcutaneous
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
D02BB02
SNOMED Codes
Code
|
Start Date
|
End Date
|
38726711000001101 |
01-07-2020 |
|
VMP Ingredients
VMP ingredients table
Afamelanotide |
Based on Ingredient Substance |
|
16 mg |
|
Name
Afamelanotide
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
16
Strength and UOM (Dmr)
Virtual Medicinal Product Pack (VMPP) Information